Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib

Overview of attention for article published in Frontiers in oncology, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 29,272 followers.

#Casereport: Complete #pathological admission in N3 unresectable locally advanced #lung #adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after #neoadjuvant #crizotinib https://t.co/tLZ3RwIpc1 https://t.co/bbSvZ4bfCv

24 Apr 2023

Reply Repost Favourite

Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib #lymphoma #lymsm https://t.co/2fVmR3Fx9C

17 Apr 2023

Reply Repost Favourite

17 Apr 2023

Reply Repost Favourite

14 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.